Skip to content

Clinical trials

Phase 3 Rare Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Phase: Phase 3 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20102
20121
20132
20141
20151
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
National Center for Research Resources (NCRR)3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Ultragenyx Pharmaceutical Inc2
AstraZeneca1
Gradalis, Inc.1
Novartis Pharmaceuticals1
Roswell Park Cancer Institute1
United Therapeutics1
Windtree Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases18
Cystinosis4
Metabolic Diseases4
Communicable Diseases3
Immune System Diseases3
Herpes Simplex2
Herpesviridae Infections2
Lysosomal Storage Diseases2
Mucopolysaccharidoses2
Mucopolysaccharidosis VII2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.